Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy
Author:
Funder
The Scientific and Technological Research Council of Turkey
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference24 articles.
1. Survivin, cancer networks and pathway-directed drug discovery;Altieri;Nat. Rev. Cancer,2008
2. Timeline: chemotherapy and the war on cancer;Chabner;Nat. Rev. Cancer,2005
3. Enhancing tumor cell response to multidrug resistance with pH-sensitive quercetin and doxorubicin conjugated multifunctional nanoparticles;Daglioglu;Colloids Surf. B Biointerfaces,2017
4. Environmentally responsive dual-targeting nanoparticles: improving drug accumulation in cancer cells as a way of preventing anticancer drug efflux;Daglioglu;J. Pharm. Sci.,2018
5. Synthesis and characterization of AICAR and DOX conjugated multifunctional nanoparticles as a platform for synergistic inhibition of cancer cell growth;Daglioglu;Bioconjug. Chem.,2016
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 3-Aminobenzamide-linked multifunctional nanoparticles enhances anticancer activity of low-dose cisplatin chemotherapy in lung adenocarcinoma;Journal of Drug Delivery Science and Technology;2024-10
2. Construction of a Silver Nanoparticle Complex and its Application in Cancer Treatment;Journal of Biomimetics, Biomaterials and Biomedical Engineering;2022-05-20
3. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance;Cancers;2021-12-07
4. Combination Therapy of Breast Cancer by Codelivery of Doxorubicin and Survivin siRNA Using Polyethylenimine Modified Silk Fibroin Nanoparticles;ACS Biomaterials Science & Engineering;2021-02-04
5. Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells;Applied Sciences;2021-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3